A Randomized Controlled Phase 2 Trial of the Blood Stage AMA1-C1/Alhydrogel Malaria Vaccine in Children in Mali

A double blind, randomized, controlled Phase 2 clinical trial was conducted to assess the safety, immunogenicity, and biologic impact of the vaccine candidate Apical Membrane Antigen 1- Combination 1 (AMA1-C1), adjuvanted with Alhydrogel(®). Participants were healthy children 2-3 years old living in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sagara, Issaka, Dicko, Alassane, Ellis, Ruth D., Fay, Michael P., Diawara, Sory I., Assadou, Mahamadoun H., Sissoko, Mahamadou S., Kone, Mamady, Diallo, Abdoulbaki I., Saye, Renion, Guindo, Merepen A., Kante, Ousmane, Niambele, Mohamed B., Miura, Kazutoyo, Mullen, Gregory E.D., Pierce, Mark, Martin, Laura B., Dolo, Amagana, Diallo, Dapa A., Doumbo, Ogobara K, Miller, Louis H, Saul, Allan
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2713037/
https://ncbi.nlm.nih.gov/pubmed/19428923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.03.014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados